MedPath

13-deoxydoxorubicin

Generic Name
13-deoxydoxorubicin
Drug Type
Small Molecule
Chemical Formula
C27H31NO10
CAS Number
628290-43-7
Unique Ingredient Identifier
1S9VO1DQG5

Overview

GPX-100 is an anthracycline anticancer drug that belongs to the family of drugs called antitumor antibiotics.

Background

GPX-100 is an anthracycline anticancer drug that belongs to the family of drugs called antitumor antibiotics.

Indication

Investigated for use/treatment in breast cancer and cancer/tumors (unspecified).

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath